$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
肺癌药物色瑞替尼多少钱?
2025-10-19 11:44:20
Check Details
肺癌靶向药色瑞替尼效果如何?
2025-10-19 11:44:20
Check Details
色瑞替尼价格与规格
2025-10-19 11:44:20
Check Details
色瑞替尼哪里买?
2025-10-19 11:44:20
Check Details
色瑞替尼什么时候吃效果好?
2025-10-19 11:44:20
Check Details
肺癌靶向药色瑞替尼说明书
2025-10-19 11:44:20
Check Details
FDA授予Cemiplimab-rwlc优先审评资格,用于一线治疗晚期NSCLC
2025-10-19 11:44:20
Check Details
克唑替尼在MET改变的非小细胞肺癌中的活性尚未确定
2025-10-19 11:44:20
Check Details
拉罗替尼适应症有什么?
2025-10-19 11:44:20
Check Details
拉罗替尼用多久见效?
2025-10-19 11:44:20
Check Details
拉罗替尼治疗什么病?
2025-10-19 11:44:20
Check Details
拉罗替尼一个月费用
2025-10-19 11:44:20
Check Details
1
2
...
9700
9701
9702
9703
9704
9705
9706
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
2
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
3
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
4
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
5
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
6
A Precision FGFR Inhibitor for Cholangiocarcinoma
7
A Revolutionary Targeted Therapy for Hematological Malignancies
8
A New Option for Advanced Renal Cell Carcinoma Treatment
9
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
10
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
11
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide